Tokyo, Japan

Kenichiro Ito

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The University of Tokyo. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenichiro Ito. Retrieved from https://idiyas.com/inventor/kenichiro-ito-b7dqkwsv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenichiro Ito: Innovator in c-Met Protein Agonists

Introduction

Kenichiro Ito is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of peptide complexes that function as c-Met protein agonists. His work has implications for cell growth and cancer research.

Latest Patents

Kenichiro Ito holds a patent for a c-Met protein agonist. This patent describes a peptide functioning as a c-Met agonist, which includes a peptide complex comprising two or more peptides that bind to a c-Met protein. The complex also features a linker that connects the peptides, promoting autophosphorylation of the c-Met protein and inducing cell growth.

Career Highlights

Kenichiro Ito is affiliated with The University of Tokyo, where he conducts research and develops innovative solutions in the field of biochemistry. His work has garnered attention for its potential applications in medical science.

Collaborations

Kenichiro Ito collaborates with Hiroaki Suga, a fellow researcher, to advance their understanding of peptide interactions and their applications in therapeutic contexts.

Conclusion

Kenichiro Ito's contributions to the field of biochemistry, particularly through his patent on c-Met protein agonists, highlight his role as an innovator in scientific research. His work continues to pave the way for advancements in cell growth and potential cancer treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…